Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate sustained-release tablets for gout and gout-related urinary stones
ChiCTR2500103288Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of potassium citrate and sodium bicarbonate in gout and nephrolithiasis (3 arms), sponsored by Huashan Hospital. Primary endpoint: Blood uric acid level at Week 48. Started May 2025; status: recruiting.
02
Drugs
potassium citratesodium bicarbonate
03
Conditions
goutnephrolithiasis
Beyond the preview
Go deeper on ChiCTR2500103288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103288.